Clinical Trial Update: Inhaled Aerosolized Prostacyclin for Pulmonary Hypertension Requiring Inhaled Nitric Oxide [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating inhaled aerosolized prostacyclin for pulmonary hypertension requiring inhaled nitric oxide was terminated; results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• prostacyclin (epoprostenol) (epoprostenol)

Snippet

Sponsor: Duke University | Conditions: Pulmonary Hypertension | Phase 4 | Status: TERMINATED | Results posted: 2014-08-26